CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Results of operations · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 144 Insider Sale of Securities
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure · Other events
- 144 Insider Sale of Securities
Page 9 of 41 · 819 filings